67
Participants
Start Date
December 18, 2019
Primary Completion Date
May 24, 2022
Study Completion Date
May 24, 2022
Patisiran
Patisiran-lipid complex injection, for intravenous use
Clinical Trial Site, Pittsburgh
Clinical Trial Site, Pittsburgh
Clinical Trial Site, Lancaster
Clinical Trial Site, Bethlehem
Clinical Trial Site, Allentown
Clinical Trial Site, Chapel Hill
Clinical Trial Site, Charlotte
Clinical Trial Site, Braselton
Clinical Trial Site, Macon
Clinical Trial Site, Jacksonville
Clinical Trial Site, Tampa
Clinical Trial Site, Germantown
Clinical Trial Site, Jackson
Clinical Trial Site, Columbus
Clinical Trial Site, Detroit
Clinical Trial Site, Milwaukee
Clinical Trial Site, Chicago
Clinical Trial Site, Chicago
Clinical Trial Site, Kansas City
Clinical Trial Site, Omaha
Clinical Trial Site, San Antonio
Clinical Trial Site, Austin
Clinical Trial Site, Aurora
Clinical Trial Site, Los Angeles
Clinical Trial Site, San Diego
Clinical Trial Site, Farmington
Clinical Trial Site, Boston
Lead Sponsor
Alnylam Pharmaceuticals
INDUSTRY